Austin Health

Title
Kikuchi's Disease Diagnosed by an Excisional Biopsy in a Patient With COVID-19.
Publication Date
2023-02
Author(s)
Al-Roubaie, Aymen
Uthuman, Ali
Aldujaili, Thair
Asadi, Khashayar
Alabbood, Majid
Subject
cervical lymphadenopathy
covid 19
excisional tissue biopsy
necrotising lymphadenopathy
s: kikuchi-fujimoto disease
Type of document
Journal Article
OrcId
#PLACEHOLDER_PARENT_METADATA_VALUE#
#PLACEHOLDER_PARENT_METADATA_VALUE#
#PLACEHOLDER_PARENT_METADATA_VALUE#
#PLACEHOLDER_PARENT_METADATA_VALUE#
#PLACEHOLDER_PARENT_METADATA_VALUE#
DOI
10.7759/cureus.35251
Abstract
COVID-19 is an ongoing pandemic caused by the novel coronavirus SARS-CoV-2. The clinical features of COVID-19 are myriad. Though it is a multisystem illness, it predominantly involves the respiratory system. There have been case reports on rare manifestations of COVID-19, of which COVID-19-related Kikuchi's disease is one of them. To our knowledge, this is the third reported case in the world. We report a lady in her late 60s with COVID-19 infection and secondary bacterial pneumonia, which necessitated ICU admission, having ongoing fever spikes with high inflammatory markers and leukopenia. She was also found to have tender cervical lymphadenopathy on the third week of illness, whose biopsy revealed histiocytic necrotizing lymphadenitis in keeping with Kikuchi's disease. The patient had an uneventful recovery in two weeks without any intervention. The pathophysiology of COVID-19-related Kikuchi's disease is unclear. However, COVID-19 is a viral illness that involves changes in interleukins. The latter is postulated in Kikuchi's disease.
Link
Citation
Cureus 2023
Jornal Title
Cureus

Files:

NameSizeformatDescriptionLink